- 1. B lymphocyte depletion therapy
- [ ] (UMLS (CSP) C1171324) =Therapeutic or Preventive Procedure
| - 51. Bladder Neck
- [The inferior portion of the urinary bladder which is formed as the walls of the bladder converge and become contiguous with the proximal urethra. ( NCI )] (UMLS (NCI) C0227716) =Body Location or Region
|
- 2. B Lymphocyte Kinase
- [Encoded by the BLK gene, p55-BLK is a non-receptor protein tyrosine kinase member of the SRC protooncogene family and, on the basis of its preferential expression in B-lymphoid cells, it may function in a signal transductory pathway specific to this lineage. Expression of BLK in immature T-cells suggests that it may play an important role in thymopoiesis. The protein has SH3, SH2, and catalytic domains that contain SRC tyrosine kinase family consensus sequences. (from OMIM 191305 and NCI) ( NCI )] (UMLS (NCI) C0218989) =Amino Acid, Peptide, or Protein; Enzyme ;
| - 52. BLADDER NECK DILATION
- (UMLS (ICD9CM) C0194542) =Therapeutic or Preventive Procedure
|
- 3. B Lymphoid Tyrosine Kinase Gene
- [This gene is involved in signal transduction in B lymphocytes. ( NCI )] (UMLS (NCI) C1332419) BLK;
BLK Gene;
=Gene or Genome | - 53. BLADDER NECK OBSTRUCTION
- [Blocked urine flow through the bladder neck, the narrow internal urethral opening at the base of the URINARY BLADDER. Narrowing or strictures of the URETHRA can be congenital or acquired. It is often observed in males with enlarged PROSTATE GLAND. ( MSH )] (UMLS (ICD9CM) C0005694) =Disease or Syndrome ;
|
- 4. BL
- [A country in Central South America, southwest of Brazil. (NCI) ( NCI )] (UMLS (NCI) C0005918) =Geographic Area
| - 54. bladder neoplasm
- [new abnormal urinary bladder tissue that grows by excessive cellular division and proliferation more rapidly than normal and continues to grow after the stimuli that initiated the new growth cease. ( CSP )] (UMLS (CSP) C0005695) =Neoplastic Process ;
|
- 5. Blaberidae
- [ ] (UMLS (CSP) C0600184) =Invertebrate
| - 55. BLADDER NEOPLASM NOS
- (UMLS (ICD9CM) C0027639) =Neoplastic Process
|
- 6. Black
- (UMLS (HL7) C0005680) =Population Group ;
| - 56. BLADDER OPERATION NEC
- [ ] (UMLS (ICD9CM) C0175594) =Therapeutic or Preventive Procedure
|
- 7. Black Adenoma
- [A usually functioning adenoma of the adrenal cortex. Grossly, it has a dark brown appearance and is characterized by the presence of neoplastic cells containing abundant intracytoplasmic lipofuscin. It may be associated with Cushing's syndrome. ( NCI )] (UMLS (NCI) C0334333) =Neoplastic Process
| - 57. Bladder Papillary Neoplasm of Low Malignant Potential
- [A papillary neoplasm of the urinary bladder in which the transitional cells form papillae. The papillary structures exhibit minimal architectural distortion and minimal atypia. Mitoses are infrequent. Patients are at an increased risk of developing new papillary lesions. Occasionally, the new lesions are urothelial carcinomas. ( NCI )] (UMLS (NCI) C1266010) Bladder Papillary Transitional Cell Neoplasm of Low Malignant Potential;
Bladder Papillary Urothelial Neoplasm of Low Malignant Potential;
Bladder PUNLMP =Neoplastic Process |
- 8. Black and Tan Coonhound
- [The Black and Tan Coonhound is a large, powerful working hound with long pendent ears. A short, sleek, black coat has tan markings on the muzzle, limbs, and chest. The droop of loosely fitting skin and extensive ear leather give the Black and Tan a distinctive quality. Height: 23-27 inches (58-68 cm.) Weight: 50-75 pounds (45-64 kg.) ( NCI )] (UMLS (NCI) C0324343) =Mammal
| - 58. Bladder Paraganglioma
- [A benign or malignant extra-adrenal sympathetic paraganglioma arising from the urinary bladder. Clinical signs include hypertension and hematuria. ( NCI )] (UMLS (NCI) C1332562) Paraganglioma of Bladder;
Paraganglioma of the Bladder;
Paraganglioma of the Urinary Bladder;
Paraganglioma of Urinary Bladder;
Urinary Bladder Paraganglioma;
=Neoplastic Process |
- 9. black ape
- [ ] (UMLS (CSP) C0085829) =Mammal ;
| - 59. BLADDER RECONSTRUCTION
- (UMLS (ICD9CM) C0194520) =Therapeutic or Preventive Procedure
|
- 10. Black Cohosh
- [A triterpene-containing herb isolated from the roots and rhizomes of the plant Cimicifuga racemosa (also known as Actaea racemosa). While the mechanism of action of black cohosh is not completely understood, it appears to act as a selective estrogen receptor modulator. In vitro, this preparation has been shown to induce cell cycle arrest and caspase-dependent apoptosis of estrogen-sensitive breast cancer cells. (NCI04) ( NCI )] (UMLS (NCI) C0771967) BLACK COHOSH EXTRACT;
BLACK COHOSH EXTRACT PREPARATION;
BLACK COHOSH PREPARATION;
=Pharmacologic Substance =Black Cohosh;
Unclassified Ingredients;
Unclassified Ingredient Preparations;
=BLACK COHOSH EXTRACT CAP/TAB;
Black Cohosh;
| - 60. BLADDER REPAIR NEC
- [ ] (UMLS (ICD9CM) C0177046) =Therapeutic or Preventive Procedure
|
- 11. Black Creek Canal virus
- [ ] (UMLS (CSP) C0872116) =Virus ;
| - 61. Bladder replaced by other means
- [ ] (UMLS (ICD9CM) C0481487) =Finding
|
- 12. black death
- [ ] (UMLS (CSP) C0282312) =Disease or Syndrome ;
| - 62. BLADDER RUPT, NONTRAUM
- [ ] (UMLS (ICD9CM) C0156275) =Disease or Syndrome ;
|
- 13. BLACK EYE NOS
- [ ] (UMLS (ICD9CM) C1442861) Black eye, NOS =Finding ;
| - 63. Bladder Sarcoma
- (UMLS (NCI) C0349666) =Neoplastic Process
|
- 14. black fly
- [black flies are widely distributed; females are vicious biters and serious pests; larvae live in streams; are the vector for onchocerciasis. ( CSP )] (UMLS (CSP) C0037162) =Invertebrate =Diptera;
| - 64. Bladder Schistosomiasis
- [A human disease caused by the infection of parasitic worms SCHISTOSOMA HAEMATOBIUM. It is endemic in AFRICA and parts of the MIDDLE EAST. Tissue damages most often occur in the URINARY TRACT, specifically the URINARY BLADDER. ( MSH )] (UMLS (NCI) C0276926) =Disease or Syndrome =bilharziasis;
Infection, Urinary Tract |
- 15. black legged tick
- [ ] (UMLS (CSP) C0282510) =Invertebrate
| - 65. Bladder Signet Ring Cell Adenocarcinoma
- (UMLS (NCI) C1332563) Signet Ring Cell Adenocarcinoma of Bladder;
Signet Ring Cell Adenocarcinoma of the Bladder;
Signet Ring Cell Adenocarcinoma of the Urinary Bladder;
Signet Ring Cell Adenocarcinoma of Urinary Bladder;
Urinary Bladder Signet Ring Adenocarcinoma;
=Neoplastic Process |
- 16. BLACK PIEDRA
- [ ] (UMLS (ICD9CM) C0153249) =Disease or Syndrome
| - 66. Bladder Small Cell/Neuroendocrine Carcinoma
- [Highly aggressive carcinomas histologically resembling lung small cell lung carcinomas. In most cases are associated with carcinoma in situ. ( NCI )] (UMLS (NCI) C1332564) Small Cell/Neuroendocrine Carcinoma of the Urinary Bladder;
Small Cell/Neuroendocrine Carcinoma of Urinary Bladder =Neoplastic Process |
- 17. Blackfeet
- (UMLS (NCI) C0337860) =Population Group ;
=American Indian;
| - 67. BLADDER SPHINCTEROTOMY
- [ ] (UMLS (ICD9CM) C0177047) =Therapeutic or Preventive Procedure
|
- 18. Blackfeet Tribe of the Blackfeet Indian Reservatio
- (UMLS (HL7) C1554238) =Population Group =NativeEntityContiguous;
| - 68. Bladder Squamous Cell Carcinoma Stage I
- [TNM staging: T1 N0 M0- T1 means tumor invades subepithelial connective tissue, N0 means no regional lymph node mets, M0 means no distant mets. ( NCI )] (UMLS (NCI) C0855188) Stage I Squamous Cell Carcinoma of Bladder;
Stage I Squamous Cell Carcinoma of the Bladder;
=Neoplastic Process |
- 19. Blackfoot
- (UMLS (HL7) C1555604) Pikanii;
=Language =Algonquian;
| - 69. bladder surgery
- [ ] (UMLS (CSP) C0194361) =Therapeutic or Preventive Procedure
|
- 20. BLACKWATER FEVER
- [A complication of MALARIA, FALCIPARUM characterized by the passage of dark red to black urine. ( MSH )] (UMLS (ICD9CM) C0005681) =Disease or Syndrome ;
| - 70. Bladder Transitional Cell Carcinoma
- [The most common morphologic subtype of urinary bladder carcinoma (over 90% of cases). It arises from the transitional epithelium. It most often affects males in their sixth and seventh decades of life. Hematuria is the most common symptom at presentation. Pathologic stage is the strongest predictor of survival. — 2003 ( NCI )] (UMLS (NCI) C0279680) =Neoplastic Process
|
- 21. BLAD DIVERTICULUM CALCUL
- (UMLS (ICD9CM) C0156265) =Disease or Syndrome ;
| - 71. Bladder Transitional Cell Papilloma
- (UMLS (NCI) C1384678) Bladder Urothelial Papilloma;
Urinary Bladder Transitional Cell Papilloma;
Urinary Bladder Urothelial Papilloma =Neoplastic Process ;
|
- 22. bladder
- [musculomembranous sac in the anterior of the pelvic cavity that serves as a reservoir for urine, which it receives through the ureters and discharges through the urethra. ( CSP )] (UMLS (NCI) C0005682) =Body Part, Organ, or Organ Component ;
| - 72. Bladder Trigone
- (UMLS (NCI) C0447586) =Body Part, Organ, or Organ Component
|
- 23. Bladder Adenocarcinoma Stage I
- [TNM stage: T1, N0, M0 (T1 is tumor that invades subepithelial connective tissue, N 0 means no lymph node metastases, M 0 means no distant metastases) from PDQ ( NCI )] (UMLS (NCI) C0855176) Stage I Bladder Adenocarcinoma =Neoplastic Process
| - 73. Bladder Villous Adenoma
- [An exophytic glandular neoplasm of the bladder, morphologically similar to its intestinal counterpart. It often coexists with in situ or infiltrating bladder adenocarcinoma. ( NCI )] (UMLS (NCI) C1336893) Urinary Bladder Villous Adenoma;
Villous Adenoma of the Urinary Bladder;
Villous Adenoma of Urinary Bladder =Disease or Syndrome |
- 24. Bladder Adenocarcinoma, Recurrent
- [A recurrence of adenocarcinoma of the bladder after a period of remission. ( NCI )] (UMLS (NCI) C0855174) Recurrent Adenocarcinoma of Bladder;
Recurrent Adenocarcinoma of the Bladder;
Recurrent Adenocarcinoma of the Urinary Bladder;
Recurrent Adenocarcinoma of Urinary Bladder;
Recurrent Bladder Adenocarcinoma;
Recurrent Urinary Bladder Adenocarcinoma;
Relapsed Adenocarcinoma of Bladder;
Relapsed Adenocarcinoma of the Bladder;
Relapsed Adenocarcinoma of the Urinary Bladder;
Relapsed Adenocarcinoma of Urinary Bladder;
Relapsed Bladder Adenocarcinoma;
Relapsed Urinary Bladder Adenocarcinoma;
=Neoplastic Process | - 74. Bladder Wall
- (UMLS (NCI) C0458421) =Body Part, Organ, or Organ Component
|
- 25. BLADDER ANASTOMOSIS NEC
- [ ] (UMLS (ICD9CM) C0177045) =Therapeutic or Preventive Procedure
| - 75. BLADDER WALL HEMORRHAGE
- [ ] (UMLS (ICD9CM) C0156276) =Pathologic Function ;
|
- 26. BLADDER CALCULUS NEC
- [ ] (UMLS (ICD9CM) C1961101) Other calculus in bladder;
=Disease or Syndrome ;
| - 76. BLADDER/URETHRA INJ-CLOS
- [ ] (UMLS (ICD9CM) C0160432) =Injury or Poisoning
|
- 27. Bladder Cancer
- [Bladder carcinoma is a carcinoma arising from the bladder epithelium. Approximately 90% of the bladder carcinomas are transitional cell carcinomas. The remainder are squamous cell carcinomas, adenocarcinomas and small cell neuroendocrine carcinomas. ( NCI )] (UMLS (NCI) C0699885) =Neoplastic Process ;
| - 77. BLADDER/URETHRA INJ-OPEN
- [ ] (UMLS (ICD9CM) C0160433) =Injury or Poisoning
|
- 28. Bladder Cancer Specific Nuclear Matrix Protein BLCA-4
- [BLCA-4 is a bladder-specific, nuclear matrix protein. Elevated levels of BLCA-4 in the urine may identify individuals with bladder cancer. (from J Urol 2000. 164:634-639 via Medscape) ( NCI )] (UMLS (NCI) C0919540) BLCA-4 =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 78. Blanoxan
- (UMLS (NCI) C0701921) =Amino Acid, Peptide, or Protein; Antibiotic
|
- 29. Bladder Cancer Stage 0
- [Stage 0 includes Ta, Tis, N0, M0 Ta: Non-invasive papillary carcinoma. Tis: Carcinoma in situ: "flat tumor". N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th Ed.) - 2003 ( NCI )] (UMLS (NCI) C0278820) =Neoplastic Process
| - 79. Blarina
- [ ] (UMLS (CSP) C1260941) =Mammal ;
|
- 30. Bladder Cancer Stage I
- [Cancer that has spread into the inner lining of the bladder but not to the muscular wall of the bladder. ( NCI )] (UMLS (NCI) C0278822) =Neoplastic Process
| - 80. Blast Cell
- [Immature blood cells. ( NCI )] (UMLS (NCI) C0368761) =Cell ;
|
- 31. Bladder Cancer, Recurrent
- [The reemergence of bladder cancer after a period of remission ( NCI )] (UMLS (NCI) C0278827) =Neoplastic Process
| - 81. Blast Cell Proliferation
- [Multiplication or reproduction by cell division of immature precursor cells that have not achieved a fully differentiated state. (NCI) ( NCI )] (UMLS (NCI) C0549414) =Neoplastic Process ;
|
- 32. Bladder Clear Cell Adenocarcinoma
- [A rare morphologic variant of bladder adenocarcinoma characterized by the presence of malignant glandular epithelial cells and clear cells distributed in a tubulo-cystic, papillary, or diffuse pattern. There is a female predilection. Clinical presentation includes hematuria and dysuria. ( NCI )] (UMLS (NCI) C1332557) Bladder Mesonephric Adenocarcinoma;
Clear Cell Adenocarcinoma of Bladder;
Clear Cell Adenocarcinoma of the Bladder;
Clear Cell Adenocarcinoma of the Urinary Bladder;
Clear Cell Adenocarcinoma of Urinary Bladder;
Urinary Bladder Clear Cell Adenocarcinoma =Neoplastic Process | - 82. Blast Cells Increased in Bone Marrow
- (UMLS (NCI) C1332565) =Finding
|
- 33. BLADDER DIAGNOS PROC NEC
- [ ] (UMLS (ICD9CM) C0177033) =Diagnostic Procedure
| - 83. Blast Cells Present
- (UMLS (NCI) C0427540) =Finding
|
- 34. BLADDER DISORDER NEC
- [ ] (UMLS (ICD9CM) C0029776) =Disease or Syndrome
| - 84. Blast Cells Present in Peripheral Blood
- (UMLS (NCI) C1332566) =Finding
|
- 35. Bladder Distention
- (UMLS (NCI) C0005687) =Sign or Symptom ;
| - 85. blast crisis
- [The phase of chronic myelogenous leukemia in which the number of immature, abnormal white blood cells in the bone marrow and blood is extremely high. ( NCI )] (UMLS (NCI) C0005699) =Neoplastic Process ;
=Cell Transformation, Neoplastic;
Chronic Granulocytic Leukemia |
- 36. Bladder Epidermoid Carcinoma
- [A squamous cell carcinoma of the bladder arising from metaplastic epithelium. It represents less than 10% of bladder carcinomas. The exception is the Middle East along the Nile Valley, where it represents the most common form of carcinoma because of the endemic nature of schistosomiasis. Bladder squamous cell carcinoma is often associated with long-standing chronic inflammation of the bladder and usually has a poor prognosis. The diagnosis of squamous cell carcinoma of the bladder should be reserved for those tumors that are predominantly keratin forming. ( NCI )] (UMLS (NCI) C0279681) =Neoplastic Process
| - 86. blastema
- [group of cells that give rise to a new individual in asexual reproduction, or to an organ or part in either normal development or regeneration. ( CSP )] (UMLS (CSP) C0596184) =Tissue ;
=Developmental Process, Multicellular;
|
- 37. BLADDER EXSTROPHY
- [A birth defect in which the URINARY BLADDER is malformed and exposed, inside out, and protruded through the ABDOMINAL WALL. It is caused by closure defects involving the top front surface of the bladder, as well as the lower abdominal wall; SKIN; MUSCLES; and the pubic bone. ( MSH )] (UMLS (ICD9CM) C0005689) =Congenital Abnormality ;
| - 87. Blastema Predominant Kidney Adenosarcoma
- [Wilms tumor of the kidney characterized by the predominance of the blastema component. ( NCI )] (UMLS (NCI) C0279609) =Neoplastic Process
|
- 38. BLADDER EXSTROPHY REPAIR
- (UMLS (ICD9CM) C0194523) =Therapeutic or Preventive Procedure
| - 88. Blastic Granulocytic Sarcoma
- [A granulocytic sarcoma composed primarily of myeloblasts (WHO 2001). ( NCI )] (UMLS (NCI) C1332567) =Neoplastic Process
|
- 39. Bladder Flat Carcinoma in Situ
- [Also known as carcinoma in situ of the urinary bladder or high grade intraurothelial neoplasia, this is a flat lesion of the transitional cell epithelium characterized by severe cytologic atypia. This lesion is confined to the urothelium, and is a precursor of invasive transitional cell carcinoma of the bladder. — 2003 ( NCI )] (UMLS (NCI) C0154091) =Neoplastic Process
| - 89. Blastic NK-Cell Lymphoma
- [An aggressive immature hematologic neoplasm formerly known as blastic NK cell lymphoma, composed of cells with a lymphoblast-like morphology. Recent evidence suggests derivation from a plasmacytoid dendritic cell precursor. Patients present with cutaneous tumors and disseminated disease. — 2005 ( NCI )] (UMLS (NCI) C1301363) CD4+/CD56+ Hematodermic Neoplasm;
Early Plasmacytoid Dendritic Cell Leukemia/Lymphoma;
Monomorphic NK-Cell Lymphoma;
Primary Cutaneous CD4+/CD56+ Hematolymphoid Neoplasm;
=Neoplastic Process |
- 40. Bladder Flat Intraepithelial Lesion
- (UMLS (NCI) C1332559) Flat Intraepithelial Lesion of the Bladder;
Flat Intraepithelial Lesion of the Urinary Bladder;
Urinary Bladder Flat Intraepithelial Lesion;
=Neoplastic Process | - 90. Blastocladiella
- [A genus of aquatic fungi of the family Blastocladiaceae, order Blastocladiales, used in the study of zoospore formation. ( MSH )] (UMLS (CSP) C0005704) =Fungus ;
|
- 41. Bladder Fundus
- (UMLS (NCI) C0447584) =Body Part, Organ, or Organ Component
| - 91. Blastocyst
- [An embryo made up of two groups of cells. One group will develop into the fetus and the other will become the placenta. ( NCI )] (UMLS (NCI) C1281743) Blastosphere;
blastula =Embryonic Structure |
- 42. Bladder Granuloma
- (UMLS (NCI) C0854437) Urinary Bladder Granuloma;
=Disease or Syndrome | - 92. Blastoid Follicular Lymphoma
- [A recently described distinct subtype of high-grade follicular center cell lymphoma, representing a transformation of conventional follicular lymphomas. Although this type of lymphoma strongly expresses BCL-2, it does not carry the characteristic t(14;18)(q32;q21) chromosomal translocation found in follicular lymphomas. Instead, extra copies of chromosome 18 are often detected. — 2004 ( NCI )] (UMLS (NCI) C1332568) =Neoplastic Process
|
- 43. Bladder Inflammatory Myofibroblastic Neoplasm
- [A multinodular intermediate fibrocytic neoplasm arising from the bladder. It is characterized by the presence of spindle-shaped myofibroblasts, and a chronic inflammatory infiltrate composed of eosinophils, lymphocytes and plasma cells. ( NCI )] (UMLS (NCI) C1336891) Bladder Inflammatory Myofibroblastic Tumor;
Inflammatory Myofibroblastic Neoplasm of Bladder;
Inflammatory Myofibroblastic Neoplasm of the Bladder;
Inflammatory Myofibroblastic Neoplasm of the Urinary Bladder;
Inflammatory Myofibroblastic Neoplasm of Urinary Bladder;
Inflammatory Myofibroblastic Tumor of Bladder;
Inflammatory Myofibroblastic Tumor of the Bladder;
Inflammatory Myofibroblastic Tumor of the Urinary Bladder;
Inflammatory Myofibroblastic Tumor of Urinary Bladder;
Urinary Bladder Inflammatory Myofibroblastic Neoplasm;
Urinary Bladder Inflammatory Myofibroblastic Tumor =Neoplastic Process | - 93. Blastoid Variant Mantle Cell Lymphoma
- (UMLS (NCI) C1332569) =Neoplastic Process
|
- 44. Bladder Injury
- (UMLS (NCI) C0403677) =Injury or Poisoning
| - 94. Blastoma
- [A malignant neoplasm composed of undifferentiated cells. ( NCI )] (UMLS (NCI) C0936282) Embryoma;
=Neoplastic Process |
- 45. Bladder Irrigation
- [Instillation of a solution into the bladder to provide cleansing or medication. (NIC96) ( NCI )] (UMLS (NCI) C0194423) =Therapeutic or Preventive Procedure
| - 95. Blastoma of Lung
- [A malignant neoplasm of the lung composed of tubular structures and immature mesenchymal elements, which may differentiate towards skeletal and smooth muscle, cartilage or a combination of muscle and cartilage. This is a nodular tumor found in the periphery of the lung. It can occur at any age. The prognosis is related to the stage of the disease at the time of resection. Pulmonary blastoma is divided into two subtypes: epithelial predominant and biphasic. ( NCI )] (UMLS (NCI) C0206629) =Neoplastic Process =lung neoplasm;
Neoplasms, Complex and Mixed |
- 46. Bladder Leiomyoma
- [A well-circumscribed benign smooth muscle neoplasm arising from the bladder. It is characterized by the presence of spindle cells with cigar-shaped nuclei, interlacing fascicles, and a whorled pattern. ( NCI )] (UMLS (NCI) C1332560) Leiomyoma of Bladder;
Leiomyoma of the Bladder;
Leiomyoma of the Urinary Bladder;
Leiomyoma of Urinary Bladder;
Urinary Bladder Leiomyoma;
=Neoplastic Process | - 96. Blastomere
- [The undifferentiated cells formed by cleavage of the fertilized ovum. This includes cells in the cleavage, morula, and blastula stages of the embryo. (MeSH) ( NCI )] (UMLS (NCI) C0005712) =Embryonic Structure ;
|
- 47. BLADDER LES DESTRUCT NEC
- [ ] (UMLS (ICD9CM) C0177039) =Therapeutic or Preventive Procedure
| - 97. Blastomyces dermatitidis
- [etiologic agent of North American blastomycosis. ( CSP )] (UMLS (CSP) C0005715) =Fungus ;
=Ascomycetes;
|
- 48. Bladder Lymphoma
- (UMLS (NCI) C1332561) Lymphoma of Bladder;
Lymphoma of the Bladder;
Lymphoma of the Urinary Bladder;
Lymphoma of Urinary Bladder;
Primary Bladder Lymphoma;
Urinary Bladder Lymphoma =Neoplastic Process | - 98. Blastomyces Dermatitidis Infection
- (UMLS (NCI) C0005717) =Disease or Syndrome ;
|
- 49. Bladder Mucosa
- (UMLS (NCI) C0227691) =Body Part, Organ, or Organ Component
| - 99. blastomycosis
- [infection caused by fungi of the genus Blastomyces. ( CSP )] (UMLS (CSP) C0005716) =Disease or Syndrome ;
=Dermatomycoses;
Fungal Infection |
- 50. Bladder Muscular Coat
- (UMLS (NCI) C1288327) =Body Part, Organ, or Organ Component
| - 100. Blasts 20 Percent or More of Bone Marrow Nucleated Cells
- (UMLS (NCI) C1332570) Blasts 20% or More of Bone Marrow Nucleated Cells =Laboratory or Test Result
|
home
